Identification of a monoclonal antibody that attenuates antiphospholipid syndrome-related pregnancy complications and thrombosis

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Mineo, Chieko ^a   Lanier, Lane ^a   Jung, Eunjeong ^a   Sengupta, Samarpita ^a   Ulrich, Victoria ^a   Sacharidou, Anastasia ^a   Tarango, Cristina ^a   Osunbunmi, Olutoye ^a   Shen, Yu Min ^a   Salmon, Jane E ^b   Brekken, Rolf A ^a   Huang, Xianming ^a   Thorpe, Philip E ^a   Shaul, Philip W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MONOCLONAL ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CELL CULTURE; COMPLICATION; FEMALE; FETUS RESORPTION; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS; TROPHOBLAST; VASCULAR ENDOTHELIUM;

ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FETAL RESORPTION; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS; TROPHOBLASTS;

EID: 85024388342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158757     Document Type: Article

References (71)

1. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat.Rev.Rheumatol. 2011; 7: 330–339. doi: 10.1038/nrrheum.2011.52 PMID: 21556027
2. Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010; 376: 1498–1509. doi: 10.1016/S0140-6736(10)60709-X PMID: 20822807
3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb.Haemost. 2006; 4: 295–306. PMID: 16420554
4. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. New England Journal of Medicine. 2013; 368: 1033–1044. doi: 10.1056/NEJMra1112830 PMID: 23484830
5. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N.Engl.J Med. 2002; 346: 752–763. PMID: 11882732
6. Ames PR, Antinolfi I, Scenna G, Gaeta G, Margaglione M, Margarita A. Atherosclerosis in thrombotic primary antiphospholipid syndrome. J.Thromb.Haemost. 2009; 7: 537–542. doi: 10.1111/j.1538-7836. 2009.03308.x PMID: 19187080
7. Der H, Kerekes G, Veres K, Szodoray P, Toth J, Lakos G et al. Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus. 2007; 16: 497–503. PMID: 17670848
8. Medina G, Casaos D, Jara LJ, Vera-Lastra O, Fuentes M, Barile L et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Annals of the Rheumatic Diseases. 2003; 62: 607–610. PMID: 12810420
9. Soltesz P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun.Rev. 2007; 6: 379–386. PMID: 17537384
10. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011; 20: 206–218. doi: 10.1177/0961203310395803 PMID: 21303837
11. de Jesus GR, Agmon-Levin N, Andrade CA, Andreoli L, Chighizola CB, Porter TF et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun.Rev. 2014; 13: 795–813. doi: 10.1016/j.autrev.2014.02.003 PMID: 24650941
12. Deruelle P, Coulon C. The use of low-molecular-weight heparins in pregnancy—how safe are they? Current Opinion in Obstetrics and Gynecology. 2007; 19: 573–577. PMID: 18007136
13. de LB, de Groot PG. Autoantibodies directed against domain I of beta2-glycoprotein I. Curr.Rheumatol. Rep. 2011; 13: 70–76. doi: 10.1007/s11926-010-0144-8 PMID: 21046294
14. de Groot PG, Meijers JC. beta(2) -Glycoprotein I: evolution, structure and function. J.Thromb.Haemost. 2011; 9: 1275–1284. doi: 10.1111/j.1538-7836.2011.04327.x PMID: 21535391
15. Del Papa N, Sheng YH, Raschi E, Kandiah DA, Tincani A, Khamashta MA et al. Human beta 2-glyco-protein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies. J Immunol. 1998; 160: 5572–5578. PMID: 9605162
16. de Groot PG, Urbanus RT. The significance of autoantibodies against beta2-glycoprotein I. Blood. 2012; 120: 266–274. doi: 10.1182/blood-2012-03-378646 PMID: 22553312
17. de LB, Pengo V, Pabinger I, Musial J, Voskuyl AE, Bultink IE et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J.Thromb.Haemost. 2009; 7: 1767–1773. doi: 10.1111/j.1538-7836.2009.03588.x PMID: 19694946
18. Li Z, Krilis SA. Anti-beta(2)-glycoprotein I antibodies and the antiphospholipid syndrome. Autoimmun. Rev. 2003; 2: 229–234. PMID: 12965172
19. Ioannou Y, Pericleous C, Giles I, Latchman DS, Isenberg DA, Rahman A. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis and Rheumatism. 2007; 56: 280–290. PMID: 17195232
20. Gharavi AE, Pierangeli SS, Colden-Stanfield M, Liu XW, Espinola RG, Harris EN. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol. 1999; 163: 2922–2927. PMID: 10453040
21. Blank M, Anafi L, Zandman-Goddard G, Krause I, Goldman S, Shalev E et al. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. International Immunology. 2007; 19: 857–865. PMID: 17576752
22. George J, Blank M, Levy Y, Meroni P, Damianovich M, Tincani A et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation. 1998; 97: 900–906. PMID: 9521339
23. Robertson SA, Roberts CT, van Beijering E, Pensa K, Sheng Y, Shi T et al. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Molecular Human Reproduction. 2004; 10: 409–416. PMID: 15100383
24. Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2. J.Clin.Invest. 2011; 121: 120–131. doi: 10.1172/JCI39828 PMID: 21123944
25. Ulrich V, Gelber SE, Vukelic M, Sacharidou A, Herz J, Urbanus RT et al. ApoE Receptor 2 mediates trophoblast dysfunction and pregnancy complications induced by antiphospholipid antibodies in mice. Arthritis Rheumatol. 2015;
26. Ulrich V, Konaniah ES, Lee WR, Khadka S, Shen YM, Herz J et al. Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice. J.Am.Heart Assoc. 2014; 3: e001369. doi: 10.1161/JAHA.114.001369 PMID: 25315347
27. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. Journal of Experimental Medicine. 2006; 203: 2165–2175. PMID: 16923853
28. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin.Invest. 2003; 112: 1644–1654. PMID: 14660741
29. Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin.Cancer Res. 2005; 11: 1551–1562. PMID: 15746060
30. Luster TA, He J, Huang X, Maiti SN, Schroit AJ, de Groot PG et al. Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. Journal of Biological Chemistry. 2006; 281: 29863–29871. PMID: 16905548
31. Gong J, Archer R, Brown M, Fisher S, Chang C, Peacock M et al. Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment. Mol.Imaging. 2013; 12: 244–256. PMID: 23651502
32. Ran S, Huang X, Downes A, Thorpe PE. Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy. Neoplasia. 2003; 5: 297–307. PMID: 14511401
33. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Experimental Cell Research. 1993; 206: 204–211. PMID: 7684692
34. Irving JA, Lysiak JJ, Graham CH, Hearn S, Han VK, Lala PK. Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta. 1995; 16: 413–433. PMID: 7479613
35. Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp.Med. 2002; 195: 211–220. PMID: 11805148
36. Ulrich V, Gelber SE, Vukelic M, Sacharidou A, Herz J, Urbanus RT et al. ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice. Arthritis Rheumatol. 2016; 68: 730–739. doi: 10.1002/art.39453 PMID: 26474194
37. He J, Luster TA, Thorpe PE. Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin.Cancer Res. 2007; 13: 5211–5218. PMID: 17785577
38. Lutters BC, Derksen RH, Tekelenburg WL, Lenting PJ, Arnout J, de Groot PG. Dimers of beta 2-glyco-protein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol.Chem. 2003; 278: 33831–33838. PMID: 12807892
39. Romay-Penabad Z, guilar-Valenzuela R, Urbanus RT, Derksen RH, Pennings MT, Papalardo E et al. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood. 2011; 117: 1408–1414. doi: 10.1182/blood-2010-07-299099 PMID: 21119114
40. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005; 85: 9–23. PMID: 15568038
41. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll.Cardiol. 2004; 44: 733–739. PMID: 15312851
42. Niimi Y, Azuma H, Hirakawa K. Repeated endothelial removal augments intimal thickening and attenuates EDRF release. Am J Physiol. 1994; 266: H1348–H1356. PMID: 7514359
43. Garcia CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. American Journal of Reproductive Immunology. 1997; 37: 118–124. PMID: 9138445
44. Di SN, Meroni PL, de PN, Raschi E, Caliandro D, De Carolis CS et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis and Rheumatism. 2000; 43: 140–150. PMID: 10643710
45. Di SN, Raschi E, Testoni C, Castellani R, D'Asta M, Shi T et al. Pathogenic role of anti-beta 2-glycopro-tein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Annals of the Rheumatic Diseases. 2005; 64: 462–467. PMID: 15256379
46. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden-Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis and Rheumatism. 2002; 46: 545–552. PMID: 11840458
47. de la Torre YM, Pregnolato F, D'Amelio F, Grossi C, Di SN, Pasqualini F et al. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the beta2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. Journal of Autoimmunity. 2012; 38: J209–J215. doi: 10.1016/j.jaut.2011.11.009 PMID: 22196923
48. Sebire NJ, Fox H, Backos M, Rai R, Paterson C, Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Human Reproduction. 2002; 17: 1067–1071. PMID: 11925407
49. Bose P, Kadyrov M, Goldin R, Hahn S, Backos M, Regan L et al. Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta. 2006; 27: 869–875. PMID: 16289730
50. Abrahams VM. Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thrombosis Research. 2009; 124: 521–525. doi: 10.1016/j.thromres.2009.07.011 PMID: 19665761
51. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biology of Reproduction. 1997; 56: 50–58. PMID: 9002632
52. Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. Journal of Autoimmunity. 1994; 7: 441–455. PMID: 7980847
53. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc.Natl.Acad.Sci.U.S.A. 1991; 88: 3069–3073. PMID: 2014226
54. Urbanus RT, Pennings MT, Derksen RH, de Groot PG. Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'. J.Thromb.Haemost. 2008; 6: 1405–1412. doi: 10.1111/j.1538-7836.2008.03021.x PMID: 18485085
55. Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A et al. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmun.Rev. 2014; 13: 685–696. doi: 10.1016/j.autrev.2014.01.053 PMID: 24468415
56. Chames P, Van RM, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. British Journal of Pharmacology. 2009; 157: 220–233. doi: 10.1111/j.1476-5381.2009.00190.x PMID: 19459844
57. Foltz IN, Karow M, Wasserman SM. Evolution and emergence of therapeutic monoclonal antibodies: what cardiologists need to know. Circulation. 2013; 127: 2222–2230. doi: 10.1161/ CIRCULATIONAHA.113.002033 PMID: 23733968
58. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov. Today. 2015; 20: 122–128. doi: 10.1016/j.drudis.2014.10.003 PMID: 25450771
59. Agostinis C, Biffi S, Garrovo C, Durigutto P, Lorenzon A, Bek A et al. In vivo distribution of beta2 glycoprotein I under various pathophysiologic conditions. Blood. 2011; 118: 4231–4238. doi: 10.1182/blood-2011-01-333617 PMID: 21791419
60. Fischetti F, Durigutto P, Pellis V, Debeus A, Macor P, Bulla R et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood. 2005; 106: 2340–2346. PMID: 15956288
61. Agostinis C, Durigutto P, Sblattero D, Borghi MO, Grossi C, Guida F et al. A non-complement-fixing antibody to beta2 glycoprotein I as a novel therapy for antiphospholipid syndrome. Blood. 2014; 123: 3478–3487. doi: 10.1182/blood-2013-11-537704 PMID: 24642748
62. Chighizola CB, Andreoli L, de Jesus GR, Banzato A, Pons-Estel GJ, Erkan D. The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Lupus. 2015; 24: 980–984. doi: 10.1177/ 0961203315572714 PMID: 25697769
63. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J.Thromb.Haemost. 2010; 8: 237–242. doi: 10. 1111/j.1538-7836.2009.03674.x PMID: 19874470
64. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis and Rheumatism. 2007; 57: 1487–1495. PMID: 18050167
65. Canti V, Castiglioni MT, Rosa S, Franchini S, Sabbadini MG, Manfredi AA et al. Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity. 2012; 45: 169–175. doi: 10.3109/08916934.2011. 593600 PMID: 21875380
66. De CS, Botta A, Santucci S, Garofalo S, Martino C, Perrelli A et al. Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clinical Reviews in Allergy and Immunology. 2010; 38: 116–124. doi: 10.1007/s12016-009-8144-z PMID: 19557318
67. Geis W, Branch DW. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clinical Obstetrics and Gynecology. 2001; 44: 2–10. PMID: 11219242
68. Motta M, Boffa MC, Tincani A, Avcin T, De CS, Lachassinne E. Follow-up of babies born to mothers with antiphospholipid syndrome: preliminary data from the European neonatal registry. Lupus. 2012; 21: 761–763. doi: 10.1177/0961203312446387 PMID: 22635225
69. Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De CS et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology.(Oxford). 2011; 50: 1684–1689.
70. Venkat-Raman N, Backos M, Teoh TG, Lo WT, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstetrics and Gynecology. 2001; 98: 235–242. PMID: 11506839
71. Giannakopoulos B, Krilis SA. How I treat the antiphospholipid syndrome. Blood. 2009; 114: 2020–2030. doi: 10.1182/blood-2009-05-220756 PMID: 19587374